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Background: Arterial blood gas analysis is the gold standard for assessing the ade-
quacy of ventilation. However, arterial blood sampling may be associated with seri-
ous complications in neonates. The aim of the study was to utilize the side-stream 
capnometry measurement of end-tidal carbon dioxide (PetCO2) via nasal cannula 
circuits and to verify the reliability of PetCO2 in reflecting the arterial blood carbon 
dioxide (PaCO2) level in nonintubated neonates.
Methods: A retrospective medical record review analysis was performed in nonin-
tubated neonates admitted to the neonatal ward in a medical center. Simultaneous 
arterial PaCO2 and PetCO2 levels were evaluated. PaCO2 and PetCO2 levels were com-
pared by paired t test and were correlated using Pearson’s correlation. The PetCO2 
bias was defined as the difference between PaCO2 and PetCO2, and was assessed by 
Bland-Altman plot analysis.
Results: A total of 34 neonates were recruited, and data of 54 pairs of PaCO2 and 
PetCO2 levels were available for comparison. The average (mean ± SD) gestational 
age was 32.5 ± 4.2 weeks, and the average birth weight was 1881 ± 1077 g. There 
was a good correlation between PetCO2 and PaCO2 levels among all paired samples 
(r = 0.809, p < 0.001). When the data were divided into those with respiratory dis-
ease (n = 34) and those without (n = 20), significant correlation between PetCO2 and 
PaCO2 levels were both noted in the former group (r = 0.823, p < 0.001) and the lat-
ter group (r = 0.770, p < 0.001). The overall average mean value of PetCO2 was lower 
than that of PaCO2 (39.4 ± 8.8 mmHg vs. 41.3 ± 9.2 mmHg, p = 0.014). The difference 
between PetCO2 and PaCO2 levels was significant only among those with respiratory 
disease (38.8 ± 9.8 mmHg vs. 41.2 ± 10.3 mmHg, p = 0.027), but not among those with-
out (40.5 ± 7.0 mmHg vs. 41.6 ± 7.2 mmHg, p = 0.289).
Conclusions: End-tidal CO2 measurement by side-stream capnometry through nasal 
cannula could provide an accurate and noninvasive estimate of PaCO2 levels in non-
intubated neonates.
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1.  Introduction
The implementation of assisted ventilation for crit-
ically ill neonates requires careful attention to the 
balance between respiratory support and the pa-
tient’s needs, such as oxygen, tidal volume, and 
transpulmonary pressure supplied, not to mention 
the potential complications.1 Arterial blood gas anal-
ysis is the gold standard for assessing the adequacy 
of ventilation, providing important information on 
oxygen delivery and carbon dioxide control in the 
blood. However, these techniques are invasive and 
in some occasions associated with serious compli-
cations such as pain, infection, arterial spasm, and 
ischemic necrosis in neonates. The advancement in 
transcutaneous pulse oximetry provides an accurate 
and noninvasive monitoring of oxygenation, detect-
ing hypoxemia before any serious clinical complica-
tions take place in the neonates.2−4
The need to efficiently evaluate the level of re-
sponse to the dynamic changes of CO2 pressures in 
neonates has become more important,5 the reason 
being that having an overly high or low arterial blood 
carbon dioxide (PaCO2) level, even for a brief period 
of time, has been attributed to long-term morbid-
ity. High PaCO2 level may increase cerebral blood 
flow and the risk of developing intraventricular he-
morrhage,6,7 while hypocarbia may increase the 
incidence of periventricular leukomalacia and bron-
chopulmonary dysplasia in critically ill neonates.8,9 
Combined together with pulse oximetry, the mea-
surement of PaCO2 provides an effective and relia-
ble approach to continuously monitor the adequacy 
of both oxygenation and ventilation in ventilated 
neonates. Capillary blood sampling and transcuta-
neous monitoring are two available alternatives 
for measuring PaCO2.10 However, capillary blood 
sampling is invasive and painful, while transcuta-
neous CO2 monitoring, which is easily interfered by 
hypoxia and acidosis, is not well tolerated in small 
babies with fragile skin.11,12
Capnometry is a novel and noninvasive technol-
ogy that can be used to verify endotracheal tube 
position during mechanical ventilation and car-
diopulmonary resuscitation.13 There are previous 
studies providing good estimation of PaCO2 by cap-
nometry in intubated neonates.14,15 Nevertheless, 
for nonintubated neonates, capnometry is not ap-
plicable because of the lack of a suitable circuit to 
directly connect to the individual for measuring the 
volume of exhaled air. In adult studies, Bowe et al16 
and Liu et al17 reported that noninvasive measure-
ment of end-tidal carbon dioxide level (PetCO2) by 
infrared capnometry via nasal cannula may provide 
a good approximation of PaCO2 in nonintubated 
patients. Using the same technique, Campbell et al18 
and Tobias et al19 also demonstrated that PetCO2 
measurement could be a useful index for assessing 
the adequacy of ventilation in pediatric patients 
during the perioperative period. Furthermore, ac-
curate estimation of PaCO2 can also be obtained by 
noninvasive monitoring of PetCO2 via nasal cannula 
in spontaneously breathing infants and children 
during events of hypocarbia, diabetic acidosis, and 
seizure.20−22 However, there is very little informa-
tion concerning the adequacy of this kind of end-
tidal carbon dioxide measurement in nonintubated 
neonates.
This study aimed to determine whether PetCO2 
measurement by capnometry via nasal cannula 
could reliably reflect PaCO2 in nonintubated neo-
nates admitted in neonatal ward.
2.  Materials and Methods
This was a retrospective review and analysis of med-
ical records. The study was approved by the Institu-
tional Review Board of National Taiwan University 
Hospital, which waived the need for informed con-
sent. From July 2004 to January 2005, measurements 
of arterial PaCO2 and PetCO2 levels by side-stream 
capnometry via nasal cannula in nonintubated neo-
nates admitted to the neonatal ward were se-
lected for analysis. Patients with congenital heart 
disease were excluded.
Exhaled CO2 volume was measured using an in-
frared analyzer capnometer (CO2SMO Plus! Model 
8000; Novametrix Medical System Inc., Wallingford, 
CT, USA), which had a dead space smaller than 1 mL 
and a response time less than 60 milliseconds. The 
nasal sampling cannula (Nasal sampling cannula-
Pediatric; Novametrix Medical System Inc.) was con-
nected to the sampling adaptor with the CAPNOSTAT 
CO2 sensor (Cat. No. 5843; Novametrix Medical 
System Inc.), and the cannula tip was inserted into 
the nostrils of the patient. Arterial blood gas ob-
tained from indwelling arterial catheters was ana-
lyzed by Automatic Blood Gas (Nova Biomedical, 
Stat 5 Profile; Nova Biomedical Co., Waltham, MA, 
USA), which was calibrated on a daily basis. Arterial 
blood gas was generally obtained 30 minutes after 
chest care, and exhaled carbon dioxide volume was 
measured simultaneously. Heart rate, respiratory 
rate, and transcutaneous oxygen saturation level 
were also routinely recorded.
All data were analyzed using the SPSS (version 
11.5; SPSS Inc., Chicago, IL, USA). Differences be-
tween PaCO2 and PetCO2 measured for all enrolled 
patients were compared by paired t test. The preci-
sion of the noninvasive technique, and the agreement 
comparing the results with PaCO2, were assessed 
by PetCO2 bias, which was defined as PaCO2 minus 
PetCO2. Bland-Altman analysis was used to determine 
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the precision and the bias.23,24 The Bland-Altman 
plot was drawn by MedCalc (version 7.5.0.0; MedCalc 
Software, Belgium). PaCO2 and PetCO2 were cor-
related using Pearson’s correlation coefficient and 
linear regression analysis. A statistically significant 
difference was defined as p value < 0.05.
3.  Results
A total of 34 patients (18 males and 16 females; 
13 term infants and 21 preterm infants) were re-
cruited, and 54 pairs of PaCO2 and PetCO2 samples 
were compared. The average gestational age of 
these patients was 32.5 ± 4.2 weeks (range: 25−40 
weeks), and the average birth body weight was 
1881 ± 1077 g (range: 630−4450 g). The diagnosis of 
respiratory disease was made in 19 patients, includ-
ing those with transient tachypnea of neonate, peri-
natal aspiration syndrome, neonatal pneumonia, and 
other symptoms. No significant complications were 
observed in the course of PetCO2 monitoring.
The PetCO2 biases (95% CI), defined as PaCO2 
minus PetCO2, among the preterm group, full term 
group, respiratory disease group, and nonrespira-
tory disease group were 1.8 ± 6.0 mmHg (−0.2 to 
3.8 mmHg), 2.3 ± 4.8 mmHg (−0.2 to 4.8 mmHg), 
2.4 ± 6.0 mmHg (0.3 to 4.5 mmHg), and 1.2 ± 4.8 mmHg 
(−1.1 to 3.4 mmHg), respectively. The Bland-Altman 
plot of the difference between the PetCO2 bias 
and the average of PaCO2 and PetCO2 levels as well 
as the linear regression curve of PaCO2 and PetCO2 
levels among all paired samples and different groups 
classified by respiratory disease are shown in the 
figures (Figures 1−3). There was a good correlation 
between PetCO2 and PaCO2 among all paired sam-
ples (n = 54, r = 0.809, p < 0.001; Figure 1B), and the 
correlation between PetCO2 and PaCO2 was also 
significant among patients with respiratory disease 
(n = 34, r = 0.823, p < 0.001) and those without (n = 20, 
r = 0.770, p < 0.001; Figures 2B and 3B).
The overall average (mean ± SD) PetCO2 values 
were significantly different from the PaCO2 values 
in 54 paired samples (PetCO2 = 39.4 ± 8.8 mmHg vs. 
PaCO2 = 41.3 ± 9.2 mmHg, p = 0.014). When the PetCO2 
values were further divided according to preterm 
(PetCO2 = 39.5 ± 9.3 mmHg vs. PaCO2 = 41.2 ± 9.6 mmHg, 
p = 0.079, n = 37) and term (PetCO2 = 39.3 ± 8.0 mmHg 
vs. PaCO2 = 41.6 ± 8.5 mmHg, p = 0.065, n = 17), there 
were no significant differences. However, when com-
paring the results based on whether the patients 
had respiratory disease or not, there was a statis-
tically significant difference between PetCO2 and 
PaCO2 in the respiratory disease group (PetCO2 = 
38.8 ± 9.8 mmHg vs. PaCO2 = 41.2 ± 10.3 mmHg, p = 
0.027, n = 34), whereas the group without respiratory 
disease had no difference (PetCO2 = 40.5 ± 7.0 mmHg 
vs. PaCO2 = 41.6 ± 7.2 mmHg, p = 0.289, n = 20).
4.  Discussion
Carbon dioxide is a product of cellular metabolism 
in the tissues, and is transported to the right heart 
via the venous system. Then, it is pumped into the 
lungs by the heart, and diffuses out into the exhaled 
air. Continuous capnometry monitors exhaled CO2 
levels noninvasively and provides important clini-
cal information for the assessment of ventilation, 
perfusion, and systemic metabolism.25,26 Monitoring 
of end-tidal CO2 by capnometry in intubated pa-
tients has already become widely used. For nonin-
tubated patients, the degree of clinical usefulness 
of PetCO2 monitoring has also improved after the 
development of side-stream circuits and nasal 
sampling apparatus.27−29 The results from previous 
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Figure 1 (A) Bland-Altman plot of difference between PetCO2 bias (PaCO2 − PetCO2) and the average of PaCO2 and 
PetCO2 [(PaCO2 + PetCO2)/2] for all neonates. (B) Linear regression of PaCO2 and PetCO2 for all neonates.
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studies suggest that noninvasive monitoring of 
PetCO2 levels measured via nasal cannula may pro-
vide a clinically useful approximation of PaCO2 in 
nonintubated pediatric patients.18−22 The applica-
tion of noninvasive capnometry is essential in neo-
nates who are not intubated but still in a vulnerable 
period requiring close monitoring. Accordingly, we 
used the side-stream capnometry method via a 
special pediatric nasal cannula to measure PetCO2 
levels in nonintubated neonates. In this study, we 
demonstrated that end-tidal CO2 levels measured 
via nasal cannula do reflect the arterial CO2 levels in 
these nonintubated neonates.
The reading and trend results of PetCO2 should be 
interpreted with caution. The presence of exhaled 
CO2 entails cardiopulmonary function and tissue per-
fusion. Several factors may contribute to the inac-
curacy of PetCO2 monitoring. Sampling errors may 
occur in patients with hypoventilation, mouth breath-
ing, or low tidal volumes that lead to low flow rates 
through the nasal cannula, causing a relatively low 
end-tidal CO2 reading.19,20,30 Alterations in the car-
diorespiratory status of the patient also affect the 
correlation between PetCO2 and PaCO2 levels.31,32 
By applying side-stream capnography in spontaneous 
breathing preterm and term infants, Tirosh et al31 
demonstrated that the distribution of end-tidal CO2 
wave patterns among preterm infants was differ-
ent from that of term infants, regardless of gesta-
tional age. The inspiration duration was correlated 
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Figure 3 (A) Bland-Altman plot of difference between PetCO2 bias (PaCO2 − PetCO2) and the average of PaCO2 and 
PetCO2 [(PaCO2 + PetCO2)/2] for neonates without respiratory disease. (B) Linear regression of PaCO2 and PetCO2 for 
neonates without respiratory disease.
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Figure 2 (A) Bland-Altman plot of difference between PetCO2 bias (PaCO2 − PetCO2) and the average of PaCO2 and 
PetCO2 [(PaCO2 + PetCO2)/2] for neonates with respiratory disease. (B) Linear regression of PaCO2 and PetCO2 for 
neonates with respiratory disease.
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with the respiratory rate only in preterm infants. 
This study suggested that although alveolar pathol-
ogy may be prevalent in preterm infants, it could 
to a certain degree be disregarded by solely using 
side-stream capnography.33 Aliwalas et al34 found 
that in intubated neonates, there was a moderate 
agreement between noninvasive PetCO2 monitoring 
methods and PaCO2 among preterm infants, but scat-
tered with a wide variation data range. They rec-
ommended that noninvasive monitoring methods 
could not be substituted for PaCO2 analysis in pre-
term infants ≤ 28 weeks’ gestation during the first 
24 postnatal hours in intubated neonates; however, 
we did not see such a wide variation except for one 
case in our nonintubated infants (Figures 1A and 
2A). Tingay et al35 showed that PetCO2 correlated 
strongly with PaCO2 and transcutaneous CO2 in in-
tubated neonates; however, PetCO2 might underes-
timate PaCO2 at a clinically unacceptable level and 
was not reliable during neonatal transport. Small 
tidal volume, higher respiratory rates, and shorter 
expiratory time in neonates may all contribute to the 
deficiency in the true alveolar gas measurement, re-
flecting the wide variation of measured values.34,35
Capnometry has been reported to be more ac-
curate for patients without respiratory disease than 
for those with respiratory compromise. Severity of 
respiratory disease was reported to affect the ac-
curacy of capnometry in several studies. The more 
severe the ventilation-perfusion mismatch, the 
higher the difference between PetCO2 and PaCO2. 
However, different results had been reported by 
previous studies.31,36−39 Using a lung injury animal 
model constructed by meconium installation, Hopper 
et al40 demonstrated that the correlation between 
PetCO2 and PaCO2 was reduced from 0.94 to 0.80, 
thus increasing the bias value from 4.23 ± 4.95 mmHg 
to 20.2 ± 15.1 mmHg. In this study, we found that the 
PetCO2 bias in patients with respiratory disease was 
higher than those in patients without respiratory 
disease (2.4 ± 6.0 mmHg vs. 1.2 ± 4.8 mmHg). Although 
it is statistically significant, most of the distribu-
tion values of the PetCO2 bias were within the lim-
its of agreement by the Bland-Altman method.23,24 
An excellent correlation between PetCO2 and PaCO2 
among the patients with respiratory disease was 
still observed.
Despite the concerns listed above, we found 
that capnometry via nasal cannula may serve as an 
effective adjunct method for tracing the trends 
and monitoring the nonintubated neonates for ab-
normal arterial CO2 values. Measurement by the same 
medical professional may contribute to a better pre-
cision in noninvasive PetCO2 monitoring, as revealed 
in our previous study.15 The respiratory therapist 
had no difficulty in maintaining the position of the 
cannula or obtaining a proper waveform in the study. 
To minimize the impact of these limiting factors, 
noninvasive monitoring methods for end-tidal CO2 
may help in reducing the necessity of the use of in-
dwelling arterial catheters and the incidence caused 
by repeated phlebotomy by withdrawing arterial 
blood samples, avoiding the thermal injury to the 
infant’s fragile skin by transcutaneous probes, and 
reducing the medical costs in caring for the nonin-
tubated neonates. With this technique, management 
decisions may also be made at the bedside in real 
time without laboratory delays, thus preventing pos-
sible fluctuations of blood PaCO2 and their associated 
long term morbidities.5−9,19,20
5.  Conclusions
We demonstrated that the end-tidal CO2 measure-
ment via nasal cannula by side-stream capnometry 
could be easily performed at the bedside and pro-
vide an accurate and noninvasive estimation of 
PaCO2 in nonintubated term and preterm neonates.
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